Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.00
Ask: 65.00
Change: 0.50 (0.79%)
Spread: 2.00 (3.175%)
Open: 63.50
High: 64.00
Low: 63.50
Prev. Close: 63.50
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restricted Common Shares to be Traded in CREST

28 Aug 2015 07:00

RNS Number : 3439X
MyCelx Technologies Corporation
28 August 2015
 

28 August 2015

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Restricted Common Shares to be traded in CREST

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces that, in accordance with Regulation (EU) No. 909/2014 of the European Parliament and of the Council of 23 July 2014 on improving securities settlement in the European Union and on central depositories (the "EU Regulation") which requires all shares traded on AIM to be capable of electronic settlement, as of 1 September 2015 the existing restricted line of common shares which trades under the ticker symbol MYXR with ISIN number USU624551078 will be eligible for settlement in CREST as Depository Interests (the "Restricted DI Line").

Holders of restricted Common Shares will be able to deposit their restricted Common Shares into CREST in exchange for Depository Interests and trade such Depository Interests in uncertificated form on AIM (the "Transfer Programme"). Restricted Common Shares which participate in the Transfer Programme will continue to be subject to the restrictions on transfer. The Restricted DI Line will continue to use the ticker symbol MYXR and ISIN number USU624551078.

Holders of restricted Common Shares who do not participate in the Transfer Programme will continue to hold their Common Shares in certificated form, which will retain their legend and the restrictions on transfer. Consequently, trading in certificated restricted Common Shares may continue to take place. However, such holders of certificated restricted Common Shares should note that certificated stock is not capable of electronic settlement in accordance with the EU Regulation and will need to be dematerialised prior to electronic settlement. No Common Shares will be deposited into CREST without the positive action of the relevant shareholder.

In general, under US securities law, Common Shares that have been in issue for more than one year and are not held by an 'affiliate' of the Company qualify for characterisation as unrestricted Common Shares ("Unrestricted Common Shares"). An affiliate for this purpose is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company or a director or officer of the Company. All Unrestricted Common Shares are eligible for migration to, and trading on, the Company's unrestricted MYX line with the ISIN number US62847T2024.

There has been no change in the Company's issued share capital. The Company will continue to have a total of 18,770,117 Common Shares admitted to trading on AIM (excluding those Common Shares admitted and not allotted under the blocklisting announced on 25 February 2011). The Company holds no Common Shares in treasury.

The Company will be writing to shareholders affected shortly to inform them of the process of moving their shares to the Restricted DI Line. 

For further information please contact:

 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

 

Tel: +1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Alexander Millar

 

Corporate Broking

Jonathan Williams

Kim Eckhof

 

Tel: +44 20 3440 6800

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

 

Tel: +44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

 

Tel: +44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFISTRIDFIE
Date   Source Headline
15th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSIssue of Equity
28th Feb 20194:54 pmRNSResults of Fundraising
28th Feb 20197:00 amRNSProposed $1.8 million Placing
13th Feb 201910:22 amRNSTrading Update
21st Dec 20187:00 amRNSHolding(s) in Company
11th Dec 20187:15 amRNSDirectorate Changes
7th Dec 20187:00 amRNSBlock Admission Interim Update
29th Nov 20187:00 amRNSNew Project Award and Trading Update
8th Oct 20187:00 amRNSNew Project Award and Trading Update
12th Sep 20187:00 amRNSHalf Year Results Statement
27th Jul 20187:00 amRNSContract Extension in Saudi Arabia
11th Jul 20181:16 pmRNSResult of Annual Meeting
7th Jun 20184:23 pmRNSBlock listing Interim Review
7th Jun 20183:42 pmRNSAnnual Financial Report
15th May 20187:00 amRNSFinal Results for the year ending 31 December 2017
19th Apr 20187:00 amRNSNew Purchase Order Award and Equipment Sale
13th Apr 201810:18 amRNSIssue of Equity
10th Apr 20187:00 amRNSPurchase Order Award & General Manager Appointment
28th Mar 201812:48 pmRNSHolding(s) in Company
16th Feb 20187:00 amRNSIssue of Equity
6th Feb 20187:00 amRNSExtension of Contract and New Project
17th Jan 20187:00 amRNSTrading Update
7th Dec 20179:46 amRNSBlock listing Interim Review
3rd Nov 201712:39 pmRNSIssue of Equity
26th Oct 20177:30 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSIssue of Equity
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement
13th Jul 20164:21 pmRNSResult of AGM
11th Jul 20167:00 amRNSHalf Year Trading Update
30th Jun 20167:00 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSMyCelx and Schlumberger Sign Upstream Agreement
9th Jun 20167:00 amRNSMailing of 2015 Annual Report and Notice of AGM
7th Jun 20163:32 pmRNSBlock listing Interim Review
17th May 20167:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.